PTGS1
PTGS1 (prostaglandin-endoperoxide synthase 1, also known as COX1, PGHS-1 and PTGHS) is a dual cyclooxygenase and peroxidase that drives prostanoid biosynthesis from arachidonate. It supports the constitutive production of prostanoids, notably in the stomach and platelets. Browse Assay Genie's current range of PTGS1 research reagents below, or read on for the biology behind the target.
PTGS1 is a bifunctional enzyme with both cyclooxygenase and peroxidase activity, and it has a central role in the prostanoid biosynthesis pathway. Prostanoids are C20 oxylipins derived mainly from arachidonate, and they contribute particularly to the inflammatory response. The cyclooxygenase activity oxygenates arachidonate to the hydroperoxy endoperoxide prostaglandin G2 (PGG2). The peroxidase activity then reduces PGG2 to the hydroxy endoperoxide prostaglandin H2 (PGH2), the precursor of all 2-series prostaglandins and thromboxanes. The reaction starts with abstraction of hydrogen at carbon 13, followed by insertion of molecular oxygen to form the endoperoxide bridge between carbons 9 and 11 that defines prostaglandins. A second oxygen molecule is then inserted to give the hydroperoxy group of PGG2. The enzyme can also use linoleate as a substrate, producing (9R)-HODE and (13S)-HODE.
The PTGS1 protein is involved in the constitutive production of prostanoids, especially in the stomach and platelets. In gastric epithelial cells it is a key step in generating prostaglandins such as PGE2, which contributes to cytoprotection. In platelets it supports the generation of thromboxane A2, which promotes platelet activation and aggregation, vasoconstriction and proliferation of vascular smooth muscle cells. The protein sits in the endoplasmic reticulum and microsome membranes and belongs to the prostaglandin G/H synthase family. Mouse and rat both have a Ptgs1 ortholog.
The PTGS1 gene is one of two genes encoding similar enzymes that convert arachidonate to prostaglandin. The encoded protein regulates angiogenesis in endothelial cells and is inhibited by nonsteroidal anti-inflammatory drugs such as aspirin. Because it works as both a cyclooxygenase and a peroxidase, it has been described as a moonlighting protein. It may also promote cell proliferation during tumour progression, and alternative splicing produces multiple transcript variants. The enzyme was previously named prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase).
PTGS1 converts arachidonate into PGH2, the precursor of 2-series prostaglandins and thromboxanes, and has a particular role in the inflammatory response.
PTGS1 contributes to thromboxane A2 generation, which promotes platelet activation and aggregation, vasoconstriction and vascular smooth muscle cell proliferation.
In gastric epithelial cells PTGS1 is a key step in producing prostaglandins such as PGE2, which plays an important role in cytoprotection.
PTGS1 regulates angiogenesis in endothelial cells and may promote cell proliferation during tumour progression.
PTGS1 is a dual cyclooxygenase and peroxidase. It oxygenates arachidonate to PGG2 and reduces PGG2 to PGH2, the precursor of all 2-series prostaglandins and thromboxanes. It supports constitutive prostanoid production, notably in the stomach and platelets.
PTGS1 is also called COX1, PGHS-1 and PTGHS, and its UniProt name is prostaglandin G/H synthase 1. It was previously named prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase). Alternative splicing gives multiple transcript variants.
PTGS1 is one of two genes encoding similar enzymes that convert arachidonate to prostaglandin. Its protein is inhibited by nonsteroidal anti-inflammatory drugs such as aspirin. Mouse and rat carry a Ptgs1 ortholog; check the datasheet of any product for its validated reactivity.
Other prostaglandin pathway enzymes and inflammation-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P23219; product specifications from Assay Genie datasheets.